Consultation on NHS England proposals for a phased launch of obesity injection
Proposals for a phased launch of the obesity injection tirzepatide have been set out, as a consultation begins.
Proposals for a phased launch of the obesity injection tirzepatide have been set out, as a consultation begins.
Today (1 October 2024) NICE is consulting on draft guidance that does not recommend elacestrant for treating a type of advanced breast cancer.
At today's meeting (25th September 2024) our board has concluded that the new severity modifier is working as intended.
NHS Talking Therapies for anxiety and depression services saw record referrals in 2023/24.
Our annual report and accounts, which summarises our key achievements from April 2023 to March 2024.
We explore how North East and North Cumbria Integrated Care Board used behaviour change techniques to implement our antimicrobial prescribing guideline on acute otitis media.
An insight into one of NICE’s most long-standing collaborative relationships.
NICE's deputy chief executive, Jonathan Benger, talks about our new approach to prioritisation.